158 related articles for article (PubMed ID: 34385076)
1. Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Semeere A; Byakwaga H; Laker-Oketta M; Freeman E; Busakhala N; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Sang E; Maurer T; Wools-Kaloustian K; Kambugu A; Martin J
Cancer Epidemiol; 2021 Oct; 74():101997. PubMed ID: 34385076
[TBL] [Abstract][Full Text] [Related]
2. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
3. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
Semeere A; Freeman E; Wenger M; Glidden D; Bwana M; Kanyesigye M; Asirwa FC; Rotich E; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Adebamowo C; Jaquet A; Dabis F; Phiri S; Bohlius J; Egger M; Yiannoutsos CT; Wools-Kaloustian K; Martin J
BMC Cancer; 2017 Sep; 17(1):611. PubMed ID: 28865422
[TBL] [Abstract][Full Text] [Related]
4. Beyond T Staging in the "Treat-All" Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa.
Freeman EE; Semeere A; McMahon DE; Byakwaga H; Laker-Oketta M; Regan S; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Wools-Kaloustian K; Bassett IV; Busakhala N; Martin J
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1119-1127. PubMed ID: 33871409
[TBL] [Abstract][Full Text] [Related]
5. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa.
Amerson E; Woodruff CM; Forrestel A; Wenger M; McCalmont T; LeBoit P; Maurer T; Laker-Oketta M; Muyindike W; Bwana M; Buziba N; Busakhala N; Wools-Kaloustian K; Martin J
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):295-301. PubMed ID: 26452066
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.
Freeman E; Semeere A; Wenger M; Bwana M; Asirwa FC; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Jaquet A; Dabis F; Yumo HA; Dusingize JC; Bangsberg D; Anastos K; Phiri S; Bohlius J; Egger M; Yiannoutsos C; Wools-Kaloustian K; Martin J
BMC Cancer; 2016 Feb; 16():65. PubMed ID: 26852390
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
Gantt S; Kakuru A; Wald A; Walusansa V; Corey L; Casper C; Orem J
Pediatr Blood Cancer; 2010 May; 54(5):670-4. PubMed ID: 20205254
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
15. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
16. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
[TBL] [Abstract][Full Text] [Related]
18. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes for children and adolescents with Kaposi sarcoma.
Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
